| (210) | Number of the EPO application | 19191396 |
| (220) | Filing date of the EPO application | 2015.12.10 |
| (80) | EPO patent specification publication (B) | EPB nr. 50/2020, 2020.12.09 |
| (110) | EPO patent number | 3593808 |
| (11) | Number of the document | MD 3593808 T2 |
| (21) | Number of the application | e 2020 0240 |
| (71) | Name(s) of applicant(s), code of the country | Tricida Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | KLAERNER Gerrit, US;
CONNOR Eric F., US;
GBUR Randi K., US;
KADE Matthew J., US;
KIERSTEAD Paul H., US;
BUYSSE Jerry M., US;
COPE Michael J., US;
BIYANI Kalpesh N., US;
NGUYEN Son H., US;
TABAKMAN Scott M., US; |
| (73) | Name(s) of owner(s), code of the country | TRICIDA Inc., US; |
| (54) | Title of the invention | Proton-binding polymers for oral administration |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 31/785 (2006.01.01); C08F 226/02 (2006.01.01); C08F 8/02 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.04.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2021.05.31 |
| (30) | Priority | 201462090287 P, 2014.12.10, US |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |